Prognostic prediction of pulmonary neuroendocrine carcinoma using a transformer-based artificial intelligence model: a two-center retrospective cohort study.
Source check: Source checked. Not independent scientific confirmation.
Finding: A two-center retrospective cohort compared a transformer-based model with conventional approaches for overall and disease-free survival prediction. The best-performing model differed by endpoint, so performance should be described by task rather than as one universal winner.
Technology: Transformer-based survival prediction model
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Transformer-based survival prediction model
- Test and result
- Two-center retrospective cohort evaluation reported model-specific discrimination for overall and disease-free survival.
- Limitation / still unknown
- Retrospective cohorts do not establish prospective clinical benefit; the strongest model varied by endpoint.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3389/fonc.2026.1948262
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.